CCP-010

N/A

Report date: 2022/11/20 20:50:23
NME

Base Information

Drug NameCCP-010
Drug Alias NameCCP-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes modulators
TargetsEnzymes
Therapy Area/IndicationsTay-Sachs Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCastle Creek Biosciences LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTay-Sachs Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A